Oldstone M B A
Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Curr Top Microbiol Immunol. 2005;296:1-17. doi: 10.1007/3-540-30791-5_1.
Molecular mimicry is defined as similar structures shared by molecules from dissimilar genes or by their protein products. Either several linear amino acids or their conformational fit may be shared, even though their origins are separate. Hence, during a viral or microbe infection, if that organism shares cross-reactive epitopes for B or T cells with the host, then the response to the infecting agent will also attack the host, causing autoimmune disease. A variation on this theme is when a second, third, or repeated infection(s) shares cross-reactive B or T cell epitopes with the first (initiating) virus but not necessarily the host. In this instance, the secondary infectious agents increase the number of antiviral/antihost effector antibodies or T cells that potentiate or precipitate the autoimmune assault. The formation of this concept initially via study of monoclonal antibody or clone T cell cross-recognition in vitro through its evolution to in vivo animal models and to selected human diseases is explored in this mini-review.
分子模拟被定义为来自不同基因的分子或其蛋白质产物所共有的相似结构。即使它们的起源不同,也可能共享几个线性氨基酸或它们的构象匹配。因此,在病毒或微生物感染期间,如果该生物体与宿主共享B细胞或T细胞的交叉反应性表位,那么对感染因子的反应也会攻击宿主,导致自身免疫性疾病。这个主题的一个变体是,第二次、第三次或反复感染与第一种(引发)病毒共享交叉反应性B细胞或T细胞表位,但不一定与宿主共享。在这种情况下,继发性感染因子会增加抗病毒/抗宿主效应抗体或T细胞的数量,从而增强或引发自身免疫攻击。本综述探讨了这一概念最初是如何通过体外单克隆抗体或克隆T细胞交叉识别研究,进而发展到体内动物模型和特定人类疾病的研究而形成的。